肿瘤整合素αvβ3受体显像的研究现状

The reasearch status quo of tumor integrin αvβ3 receptor scintigraphy

  • 摘要: 整合素αvβ3受体在多种恶性肿瘤细胞表面有高水平的表达,尤其在恶性肿瘤组织新生血管内皮细胞膜,成熟血管内皮细胞和绝大多数正常器官系统则无表达或几乎不能被探及。含有RGD(精氨酸-甘氨酸-天冬氨酸)序列的小分子多肽是整合素αvβ3受体拮抗剂,对整合素αvβ3受体具有高度的选择性与亲和力,是一类具有潜在临床应用价值的肿瘤受体显像剂。

     

    Abstract: Integrin αvβ3 receptor is not only expressed on cells surface of many malignant tumors with higher level,but expressed on the neovasculature endothelial cell membrane in malignant tumor tissue with extremely high density and has no expression or cannot be detected in mature vascular endothelial cell and most of the normal organic system.The small molecul cyclic peptides containing RGD motif is an effective antagonist for αvβ3 receptor,which have height selectivity and affinity bind to αvβ3 receptor and is one kind of potential tumor receptor imaging agnet.

     

/

返回文章
返回